Risperidone Augmentation in Patients With Schizophrenia

NCT00289861 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone
DRUG: placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]